NCT06068127

Brief Summary

This is a retrospective study assessing the effectiveness of endoscopic pyloromyotomy in patients suffering from gastroparesis and/or symptoms of delayed gastric emptying after esophagectomy with gastric pull-through. Several, mainly European, centres which perform G-POEM on a routine basis will be asked to participate. The main reason to assess the effectiveness of G-POEM in this specific subgroup of patients is the fact this specific subgroup of patients is often being excluded from trials assessing efficacy and safety of G-POEM. The participating centres will be asked to report appropriate patients among those who have undergone G-POEM since 2015 till December 2023. Patients fulfilling inclusion and not having exclusion criteria will be included into the analysis; the minimum follow-up is set to 6 months after G-POEM. The main outcome is the symptomatic response at 6, 12 and 24 months (measured by GCSI score). Other endpoints will be change in other symptoms not covered by GCSI, change in gastric emptying rate and safety of the procedure. For each enrolled patient a case report form (CRF) will be filled in and delivered to the leading centre via an online database or in other forms if preferred by the respective centres. The leading centre will be responsible for data collection and analysis.

Trial Health

60
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2023

Shorter than P25 for all trials

Geographic Reach
2 countries

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 26, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

October 5, 2023

Completed
7 days until next milestone

Study Start

First participant enrolled

October 12, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 22, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 22, 2024

Completed
Last Updated

March 15, 2024

Status Verified

March 1, 2024

Enrollment Period

5 months

First QC Date

September 26, 2023

Last Update Submit

March 14, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • GCSI score

    Gastroparesis Cardinal Symptom Index questionnaire: The score ranges from 0 to 5 for each symptom (9 questions) and these are averaged into subscores and into a total score (also ranging from 0 to 5). Higher scores indicate more severe symptoms.

    At baseline and 3, 6, 12, 24, 36 months after G-POEM

Secondary Outcomes (3)

  • Gastric emptying by scintigraphy

    At baseline and 3, 6, 12, 24, 36 months after G-POEM

  • Gastric emptying by breath test

    At baseline and 3, 6, 12, 24, 36 months after G-POEM

  • Pyloric distensibility

    At baseline and 3, 6, 12, 24, 36 months after G-POEM

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients who underwent G-POEM after esophagectomy with a gastric pull-through in any of the participating centers since January 2015 till December 2023.

You may qualify if:

  • Patients who underwent G-POEM after esophagectomy with a gastric pull-through for confirmed (scintigraphy or breath test) or presumed gastroparesis. (Some centres perform G-POEM in patients whose gastroparesis was not confirmed by a scintigraphy or a breath test, therefore it is only presumed. This particular subset of patients will be analysed separately.)
  • Total GCSI score before G-POEM at least 1.0.
  • At least 6 months follow-up after G-POEM.

You may not qualify if:

  • Organic pyloric obstruction

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Institute for Clinical and Experimental Medicine

Prague, 14021, Czechia

RECRUITING

Hôpital Nord

Marseille, France

RECRUITING

MeSH Terms

Conditions

GastroparesisEsophageal Neoplasms

Condition Hierarchy (Ancestors)

Stomach DiseasesGastrointestinal DiseasesDigestive System DiseasesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck NeoplasmsEsophageal Diseases

Central Study Contacts

Rastislav Husťak, PhD, MD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Jan Martínek, MD, PhD, AGAF

Study Record Dates

First Submitted

September 26, 2023

First Posted

October 5, 2023

Study Start

October 12, 2023

Primary Completion

March 22, 2024

Study Completion

March 22, 2024

Last Updated

March 15, 2024

Record last verified: 2024-03

Locations